Literature DB >> 2970708

Renal calculi-urate as a urokinase inhibitor.

C H van Aswegen1, A W Neitz, P J Becker, D J du Plessis.   

Abstract

The formation of renal calculi is one of the most widely studied urinary ailments. Spectrophotometric analysis of urinary inhibition on the urokinase/plasmin system revealed a significant difference between subjects with and without renal calculi (P less than 0.001). The percentage urokinase/plasmin inhibition in the two groups was 77.1% for those with, and 47.1% for those without renal calculi. Because of the significant (P less than 0.015) positive correlation (r = 0.762) between the percentage inhibition of urokinase/plasmin and urinary urate concentration, the inhibition of urate on urokinase/plasmin and on plasmin and urokinase was investigated. The urokinase/plasmin system was inhibited up to 94.4% with 0.5 mM urate. Inhibition occurred with both low and high molecular weight urokinases. In order to determine which enzyme of the complex was inhibited, each was investigated independently and a 50% inhibition of urokinase activity was obtained with 4 mM urate. It was found that the urine of stone formers contained a higher concentration of urate than the urine of healthy subjects and that at the same time there was a decrease in urinary urokinase activity in these patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2970708     DOI: 10.1007/bf00256008

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  10 in total

1.  Urinary and kidney cell plasminogen activator (urokinase).

Authors:  G H Barlow
Journal:  Methods Enzymol       Date:  1976       Impact factor: 1.600

2.  Direct fluorescent assay of urokinase and plasminogen activators of normal and malignant cells: kinetics and inhibitor profiles.

Authors:  M Zimmerman; J P Quigley; B Ashe; C Dorn; R Goldfarb; W Troll
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

3.  The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin.

Authors:  A Ichinose; K Fujikawa; T Suyama
Journal:  J Biol Chem       Date:  1986-03-15       Impact factor: 5.157

4.  Assay of urokinase activity in plasma with a chromogenic substrate.

Authors:  S Hayashi; K Yamada
Journal:  Thromb Res       Date:  1981 Jun 1-25       Impact factor: 3.944

5.  Investigation of the substrate-binding site of human plasmin using tripeptidyl-p-nitroanilide substrates.

Authors:  G Szabó; M Pozsgay; P Elödi
Journal:  Thromb Res       Date:  1980-10-15       Impact factor: 3.944

6.  An aminopeptidase occurring in pig kidney. I. An improved method of preparation. Physical and enzymic properties.

Authors:  E D Wachsmuth; I Fritze; G Pfleiderer
Journal:  Biochemistry       Date:  1966-01       Impact factor: 3.162

7.  Urate does not influence the formation of calcium oxalate crystals in whole human urine at pH 5.3.

Authors:  P C Hallson; G A Rose; S Sulaiman
Journal:  Clin Sci (Lond)       Date:  1982-04       Impact factor: 6.124

8.  Activation of plasminogen by pro-urokinase. I. Mechanism.

Authors:  H R Lijnen; C Zamarron; M Blaber; M E Winkler; D Collen
Journal:  J Biol Chem       Date:  1986-01-25       Impact factor: 5.157

9.  Urinary trypsin inhibitor and urokinase activities in renal diseases.

Authors:  N Toki; H Sumi
Journal:  Acta Haematol       Date:  1982       Impact factor: 2.195

10.  Plasminogen activator release during venous stasis and exercise as determined by a new specific assay.

Authors:  B Wiman; G Mellbring; M Rånby
Journal:  Clin Chim Acta       Date:  1983-01-24       Impact factor: 3.786

  10 in total
  7 in total

1.  The effect of calcium and magnesium ions on urinary urokinase and sialidase activity.

Authors:  C H van Aswegen; J C Dirksen van Sckalckwyk; P J du Toit; L Verster; R C Franz; D J du Plessis
Journal:  Urol Res       Date:  1992

2.  Urinary plasmin inhibits TRPV5 in nephrotic-range proteinuria.

Authors:  Kukiat Tudpor; Sergio Laínez; Arjan J Kwakernaak; Nadezda V Kovalevskaya; Sjoerd Verkaart; Siebe van Genesen; Annemiete van der Kemp; Gerjan Navis; René J M Bindels; Joost G J Hoenderop
Journal:  J Am Soc Nephrol       Date:  2012-09-27       Impact factor: 10.121

3.  Pyelonephritis: renal urokinase activity in rats on essential fatty acid diets.

Authors:  P J du Toit; C H van Aswegen; J D Nel; B Strasheim; P J Becker; D J du Plessis
Journal:  Urol Res       Date:  1994

4.  In vivo effects of urease-producing bacteria involved with the pathogenesis of infection-induced urolithiasis on renal urokinase and sialidase activity.

Authors:  P J du Toit; C H van Aswegen; J A Nel; P L Steyn; A J Ligthelm; D J du Plessis
Journal:  Urol Res       Date:  1995

5.  Effects of bacteria involved with the pathogenesis of infection-induced urolithiasis on the urokinase and sialidase (neuraminidase) activity.

Authors:  P J du Toit; C H van Aswegen; P L Steyn; A Pols; D J du Plessis
Journal:  Urol Res       Date:  1992

6.  The relationship between total urinary testosterone and renal calculi.

Authors:  C H van Aswegen; P Hurter; C A van der Merwe; D J du Plessis
Journal:  Urol Res       Date:  1989

7.  Pyelonephritis: renal urokinase and sialidase (neuraminidase) activity in rats fed a standard laboratory diet.

Authors:  C H van Aswegen; P J du Toit; J D Nel; A J Ligthelm; D J du Plessis
Journal:  Urol Res       Date:  1994
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.